6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
14m ago	WesBanco Announces First Quarter 2026 Financial Results
14m ago	BioMarin Announces Board Leadership Transition
14m ago	NHI Announces Sale of NHC Portfolio for $560 Million
14m ago	Zscaler Wins 2026 Google Cloud Partner of the Year Award for Security in the Application Category
14m ago	ARMOUR Residential REIT, Inc. Announces May 2026 Dividend Rate Per Common Share

About

Corcept Therapeutics Incorporated (NASDAQ:CORT) — investor relations, events, news, and company updates on 6ix.

Latest News

Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026

Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session

FDA Approves Corcept’s Selective Glucocorticoid Receptor Antagonist Lifyorli™ (relacorilant) Plus Nab-Paclitaxel for Treatment of Patients with Platinum-Resistant Ovarian Cancer

Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update

Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals

Financials

Revenue

$761.41 M

Market Cap

$4.52 B

P/E Ratio

51.82

EPS

0.82

Community Chat

Ask AI